Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Amino acid–insensitive mTORC1 regulation enables nutritional stress resilience in hematopoietic stem cells
Demetrios Kalaitzidis, … , David M. Sabatini, David T. Scadden
Demetrios Kalaitzidis, … , David M. Sabatini, David T. Scadden
Published March 20, 2017
Citation Information: J Clin Invest. 2017;127(4):1405-1413. https://doi.org/10.1172/JCI89452.
View: Text | PDF
Research Article Hematology Stem cells

Amino acid–insensitive mTORC1 regulation enables nutritional stress resilience in hematopoietic stem cells

  • Text
  • PDF
Abstract

The mTOR pathway is a critical determinant of cell persistence and growth wherein mTOR complex 1 (mTORC1) mediates a balance between growth factor stimuli and nutrient availability. Amino acids or glucose facilitates mTORC1 activation by inducing RagA GTPase recruitment of mTORC1 to the lysosomal outer surface, enabling activation of mTOR by the Ras homolog Rheb. Thereby, RagA alters mTORC1-driven growth in times of nutrient abundance or scarcity. Here, we have evaluated differential nutrient-sensing dependence through RagA and mTORC1 in hematopoietic progenitors, which dynamically drive mature cell production, and hematopoietic stem cells (HSC), which provide a quiescent cellular reserve. In nutrient-abundant conditions, RagA-deficient HSC were functionally unimpaired and upregulated mTORC1 via nutrient-insensitive mechanisms. RagA was also dispensable for HSC function under nutritional stress conditions. Similarly, hyperactivation of RagA did not affect HSC function. In contrast, RagA deficiency markedly altered progenitor population function and mature cell output. Therefore, RagA is a molecular mechanism that distinguishes the functional attributes of reactive progenitors from a reserve stem cell pool. The indifference of HSC to nutrient sensing through RagA contributes to their molecular resilience to nutritional stress, a characteristic that is relevant to organismal viability in evolution and in modern HSC transplantation approaches.

Authors

Demetrios Kalaitzidis, Dongjun Lee, Alejo Efeyan, Youmna Kfoury, Naema Nayyar, David B. Sykes, Francois E. Mercier, Ani Papazian, Ninib Baryawno, Gabriel D. Victora, Donna Neuberg, David M. Sabatini, David T. Scadden

×

Figure 1

Rraga is required for maintaining proper progenitor differentiation and mature hematopoietic lineage cells.

Options: View larger image (or click on image) Download as PowerPoint

Rraga is required for maintaining proper progenitor differentiation and...
(A) Quantitative PCR (qPCR) on cDNA was performed to measure levels of mRNA of Rraga (normalized to Gapdh) from the indicated cell populations from mice induced with pIpC 1 to 1.5 months previously (+/+, WT; Δ/Δ, induced Rragafl/fl MxCre; n = 2–4). (B) The frequency of LSKCD34–FLT3– gated CD150+CD48– cells in BM of mice of the indicated genotypes is shown with representative FACS plot (n = 5). Additional HSPC populations in BM (left panel) and spleen (right panel) from the mice of the indicated genotypes 1 to 1.5 months after pIpC (n = 7 for BM and n = 6–7 for spleen). HSC, Lin–7AAD–CD127–Sca1+cKit+CD34–FLT3–; STRC, Lin–7AAD–CD127–Sca1+cKit+CD34+FLT3–; LMPP, Lin–7AAD–CD127–Sca1+cKit+CD34+FLT3+. (C) The frequency of committed progenitors is shown from BM (left panel) and spleen (right panel) of mice of the indicated genotypes 1 to 1.5 months after pIpC (n = 6–7). (D) Types and total number of colonies produced in M3434 media from cells of mice are indicated (n = 3). G, granulocyte; M, macrophage/monocyte; E, erythroid; GEMM, GEM-megakaryocyte; MEG, megakaryocyte-EG. (E) The frequencies of B cells (B220), T cells (CD3), and myeloid cells (monocytes [Mac1+Gr1lo] and granulocytes [Mac1+Gr1+]) in the BM and spleen from mice of the indicated Rraga genotype 1 to 1.5 months after deletion are shown (n = 3–4). (F) Ter119/CD71 staining was performed from BM and spleen to assess erythroid fractions (F1–FIV) in control and Rraga-deleted mice 1 to 1.5 months after deletion (n = 3). See Supplemental Figure 1F for gating scheme. Error bars indicate SEM. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts